These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 23622795)

  • 1. Differentiating xanthogranulomatous cholecystitis from wall-thickening type of gallbladder cancer: added value of diffusion-weighted MRI.
    Kang TW; Kim SH; Park HJ; Lim S; Jang KM; Choi D; Lee SJ
    Clin Radiol; 2013 Oct; 68(10):992-1001. PubMed ID: 23622795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Added value of diffusion-weighted MR imaging in the diagnosis of ampullary carcinoma.
    Jang KM; Kim SH; Lee SJ; Park HJ; Choi D; Hwang J
    Radiology; 2013 Feb; 266(2):491-501. PubMed ID: 23238154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of diffusion-weighted magnetic resonance imaging in the diagnosis of gallbladder cancer.
    Kim SJ; Lee JM; Kim H; Yoon JH; Han JK; Choi BI
    J Magn Reson Imaging; 2013 Jul; 38(1):127-37. PubMed ID: 23281048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xanthogranulomatous cholecystitis: diagnostic performance of US, CT, and MRI for differentiation from gallbladder carcinoma.
    Lee ES; Kim JH; Joo I; Lee JY; Han JK; Choi BI
    Abdom Imaging; 2015 Oct; 40(7):2281-92. PubMed ID: 25952571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT and MR features of xanthogranulomatous cholecystitis: an analysis of consecutive 49 cases.
    Zhao F; Lu PX; Yan SX; Wang GF; Yuan J; Zhang SZ; Wang YX
    Eur J Radiol; 2013 Sep; 82(9):1391-7. PubMed ID: 23726123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted MRI for differentiation of benign from malignant lesions in the gallbladder.
    Lee NK; Kim S; Kim TU; Kim DU; Seo HI; Jeon TY
    Clin Radiol; 2014 Feb; 69(2):e78-85. PubMed ID: 24290779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xanthogranulomatous cholecystitis: Difficulty in differentiating from gallbladder cancer.
    Suzuki H; Wada S; Araki K; Kubo N; Watanabe A; Tsukagoshi M; Kuwano H
    World J Gastroenterol; 2015 Sep; 21(35):10166-73. PubMed ID: 26401081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for diagnosis of xanthogranulomatous cholecystitis masquerading as gallbladder cancer.
    Zhang LF; Hou CS; Liu JY; Xiu DR; Xu Z; Wang LX; Ling XF
    Chin Med J (Engl); 2012 Jan; 125(1):109-13. PubMed ID: 22340475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Added value of diffusion-weighted MRI for evaluating viable tumor of hepatocellular carcinomas treated with radiotherapy in patients with chronic liver disease.
    Park HJ; Kim SH; Jang KM; Lim S; Kang TW; Park HC; Choi D
    AJR Am J Roentgenol; 2014 Jan; 202(1):92-101. PubMed ID: 24370133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xanthogranulomatous cholecystitis--a diagnostic challenge.
    Jetley S; Rana S; Khan RN; Jairajpuri ZS
    J Indian Med Assoc; 2012 Nov; 110(11):833-7. PubMed ID: 23785925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted magnetic resonance imaging to differentiate malignant from benign gallbladder disorders.
    Kitazume Y; Taura S; Nakaminato S; Noguchi O; Masaki Y; Kasahara I; Kishino M; Tateishi U
    Eur J Radiol; 2016 Apr; 85(4):864-73. PubMed ID: 26971436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR imaging of xanthogranulomatous cholecystitis.
    Furuta A; Ishibashi T; Takahashi S; Sakamoto K
    Radiat Med; 1996; 14(6):315-9. PubMed ID: 9132812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma: An analysis of 42 cases.
    Deng YL; Cheng NS; Zhang SJ; Ma WJ; Shrestha A; Li FY; Xu FL; Zhao LS
    World J Gastroenterol; 2015 Nov; 21(44):12653-9. PubMed ID: 26640342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of malignant from benign focal splenic lesions: added value of diffusion-weighted MRI.
    Jang KM; Kim SH; Hwang J; Lee SJ; Kang TW; Lee MW; Choi D
    AJR Am J Roentgenol; 2014 Oct; 203(4):803-12. PubMed ID: 25247945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating hepatic abscess from malignant mimickers: value of diffusion-weighted imaging with an emphasis on the periphery of the lesion.
    Park HJ; Kim SH; Jang KM; Lee SJ; Park MJ; Choi D
    J Magn Reson Imaging; 2013 Dec; 38(6):1333-41. PubMed ID: 23559325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinico-pathological study of xanthogranulomatous cholecystitis].
    Kitagawa S; Nakagawa M; Yamada T; Mori Y; Simizu H; Rin S; Kurumaya H
    Nihon Geka Gakkai Zasshi; 1990 Aug; 91(8):1001-10. PubMed ID: 2233654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted MRI for differential diagnosis in gallbladder lesions with special reference to ADC cut-off values.
    Yoshioka M; Watanabe G; Uchinami H; Miyazawa H; Abe Y; Ishiyama K; Hashimoto M; Nakamura A; Yamamoto Y
    Hepatogastroenterology; 2013 Jun; 60(124):692-8. PubMed ID: 24046830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.